Andere talen Redwood Pharma AB

Aandelen

REDW

SE0021512134

Beurs gesloten - Nasdaq Stockholm Andere beurzen 18:00:00 28-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,972 ^SEK	-7,43%		-66,48%	-79,32%

12/06	Redwood Pharma geeft een update over het afstotingsproces van de bedrijfsactiva	CI
23/05	Redwood Pharma geeft update over proces om activa af te stoten	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Redwood Pharma provides a new update regarding divestment of company assets	26/06
Redwood Pharma provides an update on the process for divesting the company's assets	12/06
Redwood Pharma Provides an Update on the Process for Divesting the Company's Assets	12/06
Redwood Pharma provides an update on the company's future	23/05
Redwood Pharma Provides Update on Process to Divest Assets	23/05
Redwood Pharma's product RP501 attracted a lot of interest at ARVO in Seattle	08/05
Redwood Pharma AB's Product RP501 attracted a lot of interest at ARVO in Seattle	08/05
Two international companies begin due diligence on Redwood Pharma's product RP501 ahead of potential commercial agreements	07/05
Two International Companies Begin Due Diligence on Redwood Pharma AB's Product RP501 Ahead of Potential Commercial Agreements	07/05
Redwood Pharma's board subscribes to units in the ongoing new issue	06/05
Redwood Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024	23/04
Redwood Pharma's innovative dry eye treatment to be presented at ARVO in Seattle	28/02
Redwood Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	15/02
Redwood Pharma's CEO Martin Vidaeus in year-end interview	20/12
Redwood Pharma to participate in the JP Morgan Healthcare Conference	19/12
Redwood Pharma AB (publ) changes Certified Adviser to Carnegie Investment Bank AB (publ)	30/11
Redwood Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23/11
Redwood Pharma to participate in the NLS Days partner conference in Copenhagen	22/11
Redwood Pharma to participate in the BIO-Europe partnering conference in Munich	19-10-23
Redwood Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	07-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Redwood Pharma AB

Aandelen

REDW

SE0021512134

Andere talen

Filters